Literature DB >> 17158339

Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.

George J Dimopoulos1, Shingo Semba, Kazuyo Kitazawa, Masumi Eto, Toshio Kitazawa.   

Abstract

Ca(2+) ion is a universal intracellular messenger that regulates numerous biological functions. In smooth muscle, Ca(2+) with calmodulin activates myosin light chain (MLC) kinase to initiate a rapid MLC phosphorylation and contraction. To test the hypothesis that regulation of MLC phosphatase is involved in the rapid development of MLC phosphorylation and contraction during Ca(2+) transient, we compared Ca(2+) signal, MLC phosphorylation, and 2 modes of inhibition of MLC phosphatase, phosphorylation of CPI-17 Thr38 and MYPT1 Thr853, during alpha(1) agonist-induced contraction with/without various inhibitors in intact rabbit femoral artery. Phenylephrine rapidly induced CPI-17 phosphorylation from a negligible amount to a peak value of 0.38+/-0.04 mol of Pi/mol within 7 seconds following stimulation, similar to the rapid time course of Ca(2+) rise and MLC phosphorylation. This rapid CPI-17 phosphorylation was dramatically inhibited by either blocking Ca(2+) release from the sarcoplasmic reticulum or by pretreatment with protein kinase C inhibitors, suggesting an involvement of Ca(2+)-dependent protein kinase C. This was followed by a slow Ca(2+)-independent and Rho-kinase/protein kinase C-dependent phosphorylation of CPI-17. In contrast, MYPT1 phosphorylation had only a slow component that increased from 0.29+/-0.09 at rest to the peak of 0.68+/-0.14 mol of Pi/mol at 1 minute, similar to the time course of contraction. Thus, there are 2 components of the Ca(2+) sensitization through inhibition of MLC phosphatase. Our results support the hypothesis that the initial rapid Ca(2+) rise induces a rapid inhibition of MLC phosphatase coincident with the Ca(2+)-induced MLC kinase activation to synergistically initiate a rapid MLC phosphorylation and contraction in arteries with abundant CPI-17 content.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158339      PMCID: PMC2212616          DOI: 10.1161/01.RES.0000253902.90489.df

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

1.  Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.

Authors:  T P Woodsome; M Eto; A Everett; D L Brautigan; T Kitazawa
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

Review 2.  Regulation of smooth muscle contractile elements by second messengers.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

3.  Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.

Authors:  T Kitazawa; M Eto; T P Woodsome; D L Brautigan
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms.

Authors:  M Eto; T Kitazawa; M Yazawa; H Mukai; Y Ono; D L Brautigan
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

5.  Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle.

Authors:  B Himpens; T Kitazawa; A P Somlyo
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

6.  G-protein-mediated Ca2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation.

Authors:  T Kitazawa; B D Gaylinn; G H Denney; A P Somlyo
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

7.  Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase.

Authors:  J Feng; M Ito; K Ichikawa; N Isaka; M Nishikawa; D J Hartshorne; T Nakano
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

8.  In situ determination of [Ca2+]i threshold for translocation of the alpha-protein kinase C isoform.

Authors:  R A Khalil; C Lajoie; K G Morgan
Journal:  Am J Physiol       Date:  1994-06

9.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

Review 10.  The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.

Authors:  Yasuharu Sasaki; Masaaki Suzuki; Hiroyoshi Hidaka
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

View more
  68 in total

1.  Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.

Authors:  Jee In Kim; Mark Urban; Garbo D Young; Masumi Eto
Journal:  Am J Physiol Cell Physiol       Date:  2012-04-25       Impact factor: 4.249

2.  Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

Authors:  Hema Raina; Qingli Zhang; Albert Y Rhee; Thomas L Pallone; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

3.  Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Satoshi Matsuo; Katsuharu Kameda; Mayumi Hirano; Akira Nakamizo; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-28       Impact factor: 6.200

4.  Prolonged bed rest impairs rapid CPI-17 phosphorylation and contraction in rat mesenteric resistance arteries to cause orthostatic hypotension.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  Pflugers Arch       Date:  2017-07-17       Impact factor: 3.657

5.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

6.  Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Amanda E Garza; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2013-11-26       Impact factor: 4.030

7.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

8.  Myosin light chain kinase is necessary for tonic airway smooth muscle contraction.

Authors:  Wen-Cheng Zhang; Ya-Jing Peng; Gen-Sheng Zhang; Wei-Qi He; Yan-Ning Qiao; Ying-Ying Dong; Yun-Qian Gao; Chen Chen; Cheng-Hai Zhang; Wen Li; Hua-Hao Shen; Wen Ning; Kristine E Kamm; James T Stull; Xiang Gao; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

9.  Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1.

Authors:  Christopher J Clarke; Simon Forman; James Pritchett; Vasken Ohanian; Jacqueline Ohanian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

10.  Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1.

Authors:  Wei-Qi He; Yan-Ning Qiao; Ya-Jing Peng; Juan-Min Zha; Cheng-Hai Zhang; Chen Chen; Cai-Ping Chen; Pei Wang; Xiao Yang; Chao-Jun Li; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  Gastroenterology       Date:  2013-03-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.